Cargando…

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis

Tuberculosis is still a leading cause of death worldwide. The selection and spread of Mycobacterium tuberculosis multidrug-resistant (MDR-TB) and extensively drug-resistant strains (XDR-TB) is a severe public health problem. Recently, two different classes of chemical series, the benzothiazinones (B...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jesus Lopes Ribeiro, Ana Luisa, Degiacomi, Giulia, Ewann, Fanny, Buroni, Silvia, Incandela, Maria Loreto, Chiarelli, Laurent R., Mori, Giorgia, Kim, Jaeseung, Contreras-Dominguez, Monica, Park, Young-Sam, Han, Sung-Jun, Brodin, Priscille, Valentini, Giovanna, Rizzi, Menico, Riccardi, Giovanna, Pasca, Maria Rosalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206020/ https://www.ncbi.nlm.nih.gov/pubmed/22069462 http://dx.doi.org/10.1371/journal.pone.0026675

Ejemplares similares

Decaprenylphosphoryl-β-D-Ribose 2′-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis
por: Crellin, Paul K., et al.
Publicado: (2011)

Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis
por: Lucarelli, Anna P., et al.
Publicado: (2010)

Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
por: Mori, Giorgia, et al.
Publicado: (2020)

Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome
por: Guglierame, Paola, et al.
Publicado: (2006)

New Drugs and Novel Cellular Targets against Tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2022)

Exploring the HME and HAE1 efflux systems in the genus Burkholderia
por: Perrin, Elena, et al.
Publicado: (2010)

N-Methyl-3,5-dinitrobenzamide
por: Deng, Gui-Ming, et al.
Publicado: (2011)

N-Ethyl-3,5-dinitrobenzamide
por: Xu, Jia-Ying, et al.
Publicado: (2011)

Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
por: Fan, Dongguang, et al.
Publicado: (2023)

Biochemical and structural investigations on phosphoribosylpyrophosphate synthetase from Mycobacterium smegmatis
por: Donini, Stefano, et al.
Publicado: (2017)

Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems
por: Udine, Claudia, et al.
Publicado: (2013)

N-(2-Hydroxyethyl)-3,5-dinitrobenzamide
por: He, Li, et al.
Publicado: (2008)

N,N-Dicyclohexyl-3,5-dinitrobenzamide
por: Saeed, Sohail, et al.
Publicado: (2012)

Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatis
por: Maciąg, Anna, et al.
Publicado: (2009)

Effects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope
por: Meyer, Fabian M., et al.
Publicado: (2023)

Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients
por: Degiacomi, Giulia, et al.
Publicado: (2019)

N-(4-Bromophenyl)-3,5-dinitrobenzamide
por: Saeed, Sohail, et al.
Publicado: (2011)

Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options
por: Recchia, Deborah, et al.
Publicado: (2023)

Towards a new combination therapy for tuberculosis with next generation benzothiazinones
por: Makarov, Vadim, et al.
Publicado: (2014)

Efficient Synthesis of Benzothiazinone Analogues with Activity against Intracellular Mycobacterium tuberculosis
por: Richter, Adrian, et al.
Publicado: (2021)

In Vivo Activity of the Benzothiazinones PBTZ169 and BTZ043 against Nocardia brasiliensis
por: González-Martínez, Norma Alejandra, et al.
Publicado: (2015)

Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones
por: Madikizela, Balungile, et al.
Publicado: (2021)

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
por: Scoffone, Viola C., et al.
Publicado: (2017)

Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance
por: Buroni, Silvia, et al.
Publicado: (2009)

The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021)

In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates
por: Degiacomi, Giulia, et al.
Publicado: (2020)

Benzothiazinones Mediate Killing of Corynebacterineae by Blocking Decaprenyl Phosphate Recycling Involved in Cell Wall Biosynthesis
por: Grover, Shipra, et al.
Publicado: (2014)

Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles
por: Xiong, Lu, et al.
Publicado: (2018)

Biochemical Characterization of Glutamate Racemase—A New Candidate Drug Target against Burkholderia cenocepacia Infections
por: Israyilova, Aygun, et al.
Publicado: (2016)

Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia
por: Bazzini, Silvia, et al.
Publicado: (2011)

Novel insight into the reaction of nitro, nitroso and hydroxylamino benzothiazinones and of benzoxacinones with Mycobacterium tuberculosis DprE1
por: Richter, Adrian, et al.
Publicado: (2018)

Synthesis of 1,4-benzothiazinones from acylpyruvic acids or furan-2,3-diones and o-aminothiophenol
por: Stepanova, Ekaterina E, et al.
Publicado: (2020)

CanB, a Druggable Cellular Target in Mycobacterium tuberculosis
por: Degiacomi, Giulia, et al.
Publicado: (2023)

High Content Screening Identifies Decaprenyl-Phosphoribose 2′ Epimerase as a Target for Intracellular Antimycobacterial Inhibitors
por: Christophe, Thierry, et al.
Publicado: (2009)

The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach
por: Ball, Patrick, et al.
Publicado: (2023)

Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis
por: Piton, Jérémie, et al.
Publicado: (2018)

Crystallographic evidence for unintended benzisothiazolinone 1-oxide formation from benzothiazinones through oxidation
por: Eckhardt, Tamira, et al.
Publicado: (2020)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study
por: Buroni, Silvia, et al.
Publicado: (2018)

Animal Agrocrime: An Overlooked Biological Threat
por: Donachie, Daniel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2i5si9qlk33a5qkeic1alj5a2b